277 related articles for article (PubMed ID: 27226079)
1. Association between seasonal factors and multiple sclerosis.
Watad A; Azrielant S; Soriano A; Bracco D; Abu Much A; Amital H
Eur J Epidemiol; 2016 Nov; 31(11):1081-1089. PubMed ID: 27226079
[TBL] [Abstract][Full Text] [Related]
2. Seasonality and autoimmune diseases: The contribution of the four seasons to the mosaic of autoimmunity.
Watad A; Azrielant S; Bragazzi NL; Sharif K; David P; Katz I; Aljadeff G; Quaresma M; Tanay G; Adawi M; Amital H; Shoenfeld Y
J Autoimmun; 2017 Aug; 82():13-30. PubMed ID: 28624334
[TBL] [Abstract][Full Text] [Related]
3. Disease relapses in multiple sclerosis can be influenced by air pollution and climate seasonal conditions.
Vojinović S; Savić D; Lukić S; Savić L; Vojinović J
Vojnosanit Pregl; 2015 Jan; 72(1):44-9. PubMed ID: 26043590
[TBL] [Abstract][Full Text] [Related]
4. Melatonin Contributes to the Seasonality of Multiple Sclerosis Relapses.
Farez MF; Mascanfroni ID; Méndez-Huergo SP; Yeste A; Murugaiyan G; Garo LP; Balbuena Aguirre ME; Patel B; Ysrraelit MC; Zhu C; Kuchroo VK; Rabinovich GA; Quintana FJ; Correale J
Cell; 2015 Sep; 162(6):1338-52. PubMed ID: 26359987
[TBL] [Abstract][Full Text] [Related]
5. Epidemiology of multiple sclerosis.
Ramagopalan SV; Sadovnick AD
Neurol Clin; 2011 May; 29(2):207-17. PubMed ID: 21439437
[TBL] [Abstract][Full Text] [Related]
6. The pathology of multiple sclerosis is the result of focal inflammatory demyelination with axonal damage.
Brück W
J Neurol; 2005 Nov; 252 Suppl 5():v3-9. PubMed ID: 16254699
[TBL] [Abstract][Full Text] [Related]
7. Factors associated with onset, relapses or progression in multiple sclerosis: A systematic review.
McKay KA; Jahanfar S; Duggan T; Tkachuk S; Tremlett H
Neurotoxicology; 2017 Jul; 61():189-212. PubMed ID: 27045883
[TBL] [Abstract][Full Text] [Related]
8. Mediterranean weather conditions and exacerbations of multiple sclerosis.
Saaroni H; Sigal A; Lejbkowicz I; Miller A
Neuroepidemiology; 2010 Aug; 35(2):142-51. PubMed ID: 20571282
[TBL] [Abstract][Full Text] [Related]
9. Inflammation, demyelination, and degeneration - recent insights from MS pathology.
Stadelmann C; Wegner C; Brück W
Biochim Biophys Acta; 2011 Feb; 1812(2):275-82. PubMed ID: 20637864
[TBL] [Abstract][Full Text] [Related]
10. Update on multiple sclerosis, its diagnosis and treatments.
Cross AH; Cross KA; Piccio L
Clin Chem Lab Med; 2012 Mar; 50(7):1203-10. PubMed ID: 22850053
[TBL] [Abstract][Full Text] [Related]
11. Season of birth and not vitamin D receptor promoter polymorphisms is a risk factor for multiple sclerosis.
Fernandes de Abreu DA; Babron MC; Rebeix I; Fontenille C; Yaouanq J; Brassat D; Fontaine B; Clerget-Darpoux F; Jehan F; Feron F
Mult Scler; 2009 Oct; 15(10):1146-52. PubMed ID: 19965563
[TBL] [Abstract][Full Text] [Related]
12. Towards a comprehensive etiopathogenetic and pathophysiological theory of multiple sclerosis.
Tobore TO
Int J Neurosci; 2020 Mar; 130(3):279-300. PubMed ID: 31588832
[No Abstract] [Full Text] [Related]
13. Inflammation, demyelination, neurodegeneration and neuroprotection in the pathogenesis of multiple sclerosis.
Peterson LK; Fujinami RS
J Neuroimmunol; 2007 Mar; 184(1-2):37-44. PubMed ID: 17196667
[TBL] [Abstract][Full Text] [Related]
14. [Axonal damage in multiple sclerosis].
Bartosik-Psujek H; Stelmasiak Z
Neurol Neurochir Pol; 2002; 36(3):505-12. PubMed ID: 12185807
[TBL] [Abstract][Full Text] [Related]
15. Chaos theory for clinical manifestations in multiple sclerosis.
Akaishi T; Takahashi T; Nakashima I
Med Hypotheses; 2018 Jun; 115():87-93. PubMed ID: 29685206
[TBL] [Abstract][Full Text] [Related]
16. Investigating the potential link between lunar cycle and multiple sclerosis relapses: a call for further studies.
Yousfi N; Mrabet S; Ben Saad H; Chamari K
Libyan J Med; 2023 Dec; 18(1):2238354. PubMed ID: 37476952
[TBL] [Abstract][Full Text] [Related]
17. Time of birth, residential solar radiation and age at onset of multiple sclerosis.
McDowell TY; Amr S; Langenberg P; Royal W; Bever C; Culpepper WJ; Bradham DD
Neuroepidemiology; 2010; 34(4):238-44. PubMed ID: 20299805
[TBL] [Abstract][Full Text] [Related]
18. Inflammatory demyelination is not central to the pathogenesis of multiple sclerosis.
Brück W
J Neurol; 2005 Nov; 252 Suppl 5():v10-5. PubMed ID: 16254696
[TBL] [Abstract][Full Text] [Related]
19. [Axonal degeneration in the pathogenesis of multiple sclerosis].
Mirowska D; Członkowska A
Neurol Neurochir Pol; 2002; 36(4):777-89. PubMed ID: 12418141
[TBL] [Abstract][Full Text] [Related]
20. Natalizumab therapy of multiple sclerosis.
Hutchinson M
J Interferon Cytokine Res; 2010 Oct; 30(10):787-9. PubMed ID: 20874255
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
